{'fraction_non_alphanumeric': 0.02262443438914027, 'fraction_numerical': 0.03469079939668175, 'mean_word_length': 4.579831932773109, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Chemotherapy of lung cancer.

POPULATION-BASED statistics on lung cancer in the United States must give pause even to hardened optimists. Carcinoma of the lung was the second most common cancer and the leading cause of death from cancer last year.1 Therapeutic results in this disease have been stagnant, with only a minimal increase in five-year survival between 1974 and 1987.2 Although a reduction in cigarette smoking began to produce an age-adjusted decrease in the incidence of disease among men in about 1988, the incidence among women is moving in the opposite direction, more than doubling between 1973 and 1988.2 Furthermore, even if all cigarette . . .